 |
| 23-Aug-12 | Upgrade |
UBS |
Neutral → Buy |
$25 → $22 |
|
| 31-Jul-12 | Downgrade |
William Blair |
Outperform → Mkt Perform |
|
|
| 01-May-12 | Reiterated |
UBS |
Neutral |
$22 → $25 |
|
| 12-Mar-10 | Initiated |
Jefferies & Co |
Buy |
$20 |
|
| 18-Nov-09 | Initiated |
William Blair |
Mkt Perform |
|
|
| 08-May-09 | Reiterated |
Wedbush Morgan |
Buy |
$26 → $28 |
|
| 14-Apr-09 | Initiated |
Piper Jaffray |
Neutral |
|
|
| 12-Dec-08 | Downgrade |
Leerink Swann |
Outperform → Mkt Perform |
|
|
| 16-Oct-08 | Initiated |
UBS |
Neutral |
|
|
| 10-Oct-08 | Initiated |
Cowen & Co |
Neutral |
|
|
| 08-Aug-08 | Reiterated |
Canaccord Adams |
Buy |
$24 → $26 |
|
| 15-Jul-08 | Reiterated |
Canaccord Adams |
Buy |
$22 → $24 |
|
| 08-Feb-08 | Reiterated |
Avondale Partners |
Mkt Outperform |
$22 → $24 |
|
| 01-Feb-08 | Initiated |
GARP Research |
Buy |
|
|
| 16-Jan-08 | Initiated |
Avondale Partners |
Mkt Outperform |
$22 |
|
| 29-Oct-07 | Downgrade |
Pacific Growth Equities |
Buy → Neutral |
$17.50 |
|
| 11-Sep-07 | Initiated |
Canaccord Adams |
Buy |
$17 |
|
| 20-Mar-07 | Initiated |
Thomas Weisel |
Overweight |
$18.50 |
|
|
|
| 21-May-13 03:42PM | Luminex's CEO Presents at UBS Global Healthcare Conference (Transcript) at Seeking Alpha |
| 11:27AM | In Insider Trading, Tesla Motors Sees a Sale While MoSys CEO Buys Shares Minyanville |
| 20-May-13 10:40AM | Monday 5/20 Insider Buying Report: LMNX, GFF at Forbes |
| 09:43AM | LUMINEX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 17-May-13 11:34AM | Genomic Health Director Buys More Than 52K Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet |
| 10:59AM | Finding Value in the Medical Products and Device Spaces: An Experienced Portfolio Manager Discusses Investing in Overlooked Health Care Areas Wall Street Transcript |
| 09-May-13 09:37AM | Luminex Director Buys More Than 54K Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet |
| 08-May-13 09:10AM | SPX Corp Part-Owner Buys More Than 196K Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet |
| 07-May-13 04:05PM | Luminex Corporation To Present At Upcoming Investment Conferences PR Newswire |
| 09:01AM | Opko Health CEO Buys More Than 27K Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet |
| 06-May-13 12:41PM | Top Buys by Directors: Loewenbaum II's $421.6K Bet on LMNX at Forbes |
| 10:38AM | Monday 5/6 Insider Buying Report: LMNX, NEM at Forbes |
| 04-May-13 01:04PM | LUMINEX CORP Financials EDGAR Online Financials |
| 01-May-13 05:05AM | Luminex Beats 1Q Earnings Est. Zacks -6.73% |
| 30-Apr-13 11:34AM | Bullish Two Hundred Day Moving Average Cross - LMNX at TheStreet |
| 04:40AM | LUMINEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 29-Apr-13 11:04PM | Luminex Corporation's CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 05:55PM | Luminex Earnings: Heres Why Investors Like These Results at Wall St. Cheat Sheet |
| 05:00PM | Luminex Corp Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:18PM | InPlay: Luminex beats by $0.11, beats on revs; reaffirms FY13 revs guidance Briefing.com |
| 04:05PM | Luminex Corporation Reports First Quarter 2013 Results PR Newswire |
| 09:11AM | LUMINEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 07:35AM | Luminex Corp Earnings Call scheduled for 5:00 pm ET today CCBN |
| 07:07AM | Q1 2013 Luminex Corp Earnings Release - After Market Close CCBN |
| 22-Apr-13 12:51PM | A Monopoly, A Duopoly, And A Flyer at Forbes |
| 19-Apr-13 01:40PM | FDA Nod for Luminex Offering Zacks |
| 15-Apr-13 08:03PM | 3 Healthcare Stock Stories Not To Be Missed at Wall St. Cheat Sheet |
| 08:32AM | InPlay: Luminex Receives U.S. FDA clearance for MAGPIX instrument with novel xTAG gastrointestinal pathogen panel Briefing.com |
| 08:32AM | Luminex receives FDA clearance for Magpix instrument theflyonthewall.com |
| 08:30AM | Luminex Corporation Receives U.S. FDA Clearance for MAGPIX® Instrument with Novel xTAG® Gastrointestinal Pathogen Panel PR Newswire |
| 08-Apr-13 04:05PM | Luminex Corporation First Quarter Earnings Release Scheduled for April 29, 2013 PR Newswire |
| 27-Mar-13 09:54AM | On The Fly: Analyst Initiation Summary theflyonthewall.com |
| 26-Mar-13 10:04AM | On The Fly: Analyst Initiation Summary theflyonthewall.com |
| 25-Mar-13 08:07AM | LUMINEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 19-Mar-13 03:43PM | Merck-Luminex' Alzheimer's Collaboration Zacks |
| 14-Mar-13 03:48PM | 4 Healthcare Stock Stories for Thursday Investment Wellness at Wall St. Cheat Sheet |
| 13-Mar-13 06:30PM | Merck's Companion in the Fight Against Alzheimer's at Motley Fool |
| 09:33AM | InPlay: Luminex and Merck (MRK) enter agreement to develop companion diagnostic to support investigational BACE inhibitor clinical development program for Alzheimer's Disease Briefing.com |
| 08:34AM | Merck and Luminex to develop diagnostic device for Alzheimer's candidate theflyonthewall.com |
| 08:30AM | Merck and Luminex Corporation Enter Agreement to Develop Companion Diagnostic to Support Investigational BACE inhibitor Clinical Development Program for Alzheimers Disease Business Wire |
| 11-Mar-13 09:42AM | LUMINEX CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 05-Mar-13 11:41AM | Luminex Has Both Many Opportunities And Many Questions To Answer at Seeking Alpha |
| 01-Mar-13 09:05AM | Why Luminex May Be About to Take Off at Motley Fool |
| 27-Feb-13 01:04PM | LUMINEX CORP Financials EDGAR Online Financials |
| 22-Feb-13 10:01AM | LUMINEX CORP Files SEC form 8-K, Other Events EDGAR Online |
| 08-Feb-13 09:54AM | Why Luminex Is Poised to Keep Plunging at Motley Fool |
| 06-Feb-13 07:36PM | New Star Analyst Rankings for Luminex Corporation StarMine |
| 05-Feb-13 09:38AM | Luminex Beats EPS, Profits Up Zacks |
| 04-Feb-13 11:18PM | Luminex's CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 10:30PM | Luminex Beats on Both Top and Bottom Lines at Motley Fool |
| 05:00PM | Luminex Corp Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:46PM | Luminex Corp Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:14PM | LUMINEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:05PM | Luminex Corporation Reports Fourth Quarter And Full Year 2012 Results PR Newswire |
| 07:36AM | Luminex Corp Earnings Call scheduled for 5:00 pm ET today CCBN |
| 07:07AM | Q4 2012 Luminex Corp Earnings Release - After Market Close CCBN |
| 01-Feb-13 01:12PM | Luminex Earnings Up Next at Motley Fool |
| 31-Jan-13 04:05PM | Luminex Corporation To Present At Leerink Swann Global Healthcare Conference PR Newswire |
| 26-Jan-13 09:04AM | Don't Get Too Worked Up Over Luminex's Earnings at Motley Fool |
| 17-Jan-13 03:29PM | FDA Approves Luminex Gastrointestinal Diagnostic Test at Motley Fool |
| 01:10PM | Luminex's 5-Hour Gastroenteritis Test Impresses FDA at Seeking Alpha |
| 16-Jan-13 04:05PM | Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 4, 2013 PR Newswire |
| 01:58PM | Luminex Wins FDA Clearance Zacks |
| 15-Jan-13 04:40PM | 4 Healthcare Stock Stories Not to be Missed at Wall St. Cheat Sheet |
| 08:32AM | InPlay: Luminex receives FDA Clearance for first comprehensive gastrointestinal pathogen infectious disease diagnostic in the U.S. Briefing.com |
| 08:30AM | Luminex Receives FDA Clearance for First Comprehensive Gastrointestinal Pathogen Infectious Disease Diagnostic in the United States PR Newswire |
| 11-Jan-13 03:14PM | Everything Is Growing Except The Price: 19 Growth Stocks To Consider at Seeking Alpha |
| 07-Jan-13 06:08PM | Illumina Wins One and Loses One at Motley Fool |
| 12:50PM | Whats Next for Illumina After Roche Deal Falls Through? at Wall St. Cheat Sheet |
| 02-Jan-13 04:05PM | Luminex Corporation To Present At JP Morgan Healthcare Conference PR Newswire |
| 20-Dec-12 07:41PM | UBS And Hedge Funds Disagree On These 4 Stocks at Seeking Alpha |
| 18-Dec-12 11:29AM | Luminex Retained at Neutral Zacks |
| 27-Nov-12 04:10PM | Check This to Find Out Whether Luminex Is Going to Bomb at Motley Fool |
| 04:05PM | Luminex Corporation To Host Investor Event December 11, 2012 PR Newswire |
| 15-Nov-12 11:28AM | Roche Seeking Gene Sequencing Partner at Seeking Alpha |
| 05-Nov-12 05:00PM | This Metric Suggests You're Right to Own Luminex. at Motley Fool |
| 04:55PM | Roche Seeking Gene Sequencing Partner at Seeking Alpha |
| 03-Nov-12 01:04PM | LUMINEX CORP Financials EDGAR Online Financials |
| 30-Oct-12 06:09PM | Luminex Increases Sales but Misses Revenue Estimate at Motley Fool |
| 02:48PM | LUMINEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 09:29AM | Luminex Misses Ests., Trims Outlook Zacks |
| 29-Oct-12 05:50PM | Luminex reports lower 3Q earnings at bizjournals.com |
| 05:00PM | Luminex Corp Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:27PM | LUMINEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:07PM | InPlay: Luminex misses by $0.03, misses on revs; guides FY12 revs below consensus Briefing.com |
| 04:05PM | Luminex Corporation Reports Third Quarter 2012 Results PR Newswire |
| 03:28PM | Hurricane Sandy forces Cirrus, other cos. to delay earnings reports at bizjournals.com |
| 07:07AM | Q3 2012 Luminex Corp Earnings Release - After Market Close CCBN |
| 27-Oct-12 02:18AM | Luminex, in the Spotlight Soon at Motley Fool |
| 09-Oct-12 02:18PM | 5 Highly Liquid Small Cap Stocks Projected For Strong Growth at Seeking Alpha |
| 08-Oct-12 04:05PM | Luminex Corporation Third Quarter Earnings Release Scheduled for October 29, 2012 PR Newswire |
| 01-Oct-12 09:00AM | Luminex Corporation Participates in Community Initiatives to Save Lives PR Newswire |
| 29-Sep-12 04:09AM | Qiagen: Downside Priced In, CDx And Automation Upside, Undervalued Compared To Peers at Seeking Alpha |
| 18-Sep-12 12:16PM | LUMINEX CORP Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositi EDGAR Online |
| 17-Sep-12 03:54PM | Luminex Remains Neutral Zacks |
| 12-Sep-12 04:05PM | Luminex Corporation To Present At Upcoming Investment Conferences In September PR Newswire |
| 01:09PM | Round-up: Investors buy land, McDonald's ground lease at bizjournals.com |
| 10-Sep-12 12:01AM | Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco PR Newswire |
| 07-Sep-12 11:14AM | Luminex Wins Technology Award Zacks |
| 06-Sep-12 10:41AM | On The Fly: Analyst Upgrade Summary theflyonthewall.com |
|
|
| Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. It offers xMAP technology, an open architecture and multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres; and MultiCode technology used for real-time polymerase chain reaction (PCR) and multiplexed PCR assays, as well as automation and robotics in the field of dry sample handling. It operates in two segments, Technology and Strategic Partnerships; and Assays and Related Products. The Technology and Strategic Partnerships segment provides Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; and MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids. This segment also offers consumables comprising dyed polystyrene microspheres and sheath fluids. The Assays and Related Products segment develops and sells assays on xMAP technology for use on its installed base of systems. This segment’s products are focused on the human genetics, personalized medicine, and infectious disease segments of the genetic testing market. This segment provides various assay products, which consist of a combination of chemical and biological reagents, and company’s proprietary bead technology used to perform diagnostic and research assays on samples. It serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions in the United States, Europe, Asia, Canada, and Australia. The company has a collaboration and license agreement with Merck & Co., Inc. to develop a companion diagnostic device. Luminex Corporation was founded in 1995 and is headquartered in Austin, Texas. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| GOAD FRED C JR | Director | May 16 | Buy | 18.18 | 8,000 | 145,439 | 337,579 | May 20 11:58 AM | | LOEWENBAUM G WALTER II | Director | May 16 | Buy | 17.89 | 7,500 | 134,175 | 738,062 | May 20 11:41 AM | | LOEWENBAUM G WALTER II | Director | May 15 | Buy | 18.07 | 19,500 | 352,316 | 720,127 | May 16 10:02 AM | | LOEWENBAUM G WALTER II | Director | May 14 | Buy | 18.57 | 20,000 | 371,412 | 700,627 | May 16 10:02 AM | | LOEWENBAUM G WALTER II | Director | May 10 | Buy | 18.13 | 19,000 | 344,487 | 680,627 | May 14 12:06 PM | | REITER DAVID S | SVP & General Counsel | May 10 | Sale | 18.26 | 10,000 | 182,589 | 78,794 | May 14 11:59 AM | | LOEWENBAUM G WALTER II | Director | May 09 | Buy | 17.20 | 11,000 | 189,160 | 661,627 | May 10 11:41 AM | | LOEWENBAUM G WALTER II | Director | May 08 | Buy | 17.22 | 17,300 | 297,954 | 650,627 | May 10 11:41 AM | | LOEWENBAUM G WALTER II | Director | May 07 | Buy | 17.20 | 54,635 | 939,542 | 633,327 | May 07 05:31 PM | | LOEWENBAUM G WALTER II | Director | May 06 | Buy | 17.02 | 10,300 | 175,324 | 578,692 | May 07 05:31 PM | | LOEWENBAUM G WALTER II | Director | May 03 | Buy | 17.09 | 20,000 | 341,800 | 568,392 | May 06 09:45 AM | | LOEWENBAUM G WALTER II | Director | May 02 | Buy | 16.74 | 4,765 | 79,766 | 548,392 | May 06 09:45 AM | | REITER DAVID S | VP & General Counsel | Feb 28 | Option Exercise | 8.41 | 40,000 | 336,400 | 107,216 | Mar 04 09:33 AM | | REITER DAVID S | VP & General Counsel | Feb 28 | Sale | 16.78 | 26,100 | 437,932 | 81,116 | Mar 04 09:33 AM | | ERICKSON THOMAS W | Director | Feb 27 | Option Exercise | 4.68 | 32,425 | 151,749 | 99,873 | Feb 28 09:46 AM | | ERICKSON THOMAS W | Director | Feb 27 | Sale | 16.85 | 32,425 | 546,384 | 67,448 | Feb 28 09:46 AM | | ERICKSON THOMAS W | Director | Feb 26 | Option Exercise | 4.68 | 9,175 | 42,939 | 76,623 | Feb 28 09:46 AM | | ERICKSON THOMAS W | Director | Feb 26 | Sale | 16.82 | 9,175 | 154,355 | 67,448 | Feb 28 09:46 AM | | ERICKSON THOMAS W | Director | Feb 22 | Option Exercise | 4.68 | 900 | 4,212 | 68,348 | Feb 26 12:32 PM | | ERICKSON THOMAS W | Director | Feb 22 | Sale | 17.38 | 900 | 15,642 | 67,448 | Feb 26 12:32 PM | | ERICKSON THOMAS W | Director | Feb 21 | Option Exercise | 4.68 | 25,000 | 117,000 | 92,448 | Feb 22 10:38 AM | | ERICKSON THOMAS W | Director | Feb 21 | Sale | 17.33 | 25,000 | 433,255 | 67,448 | Feb 22 10:38 AM | | ERICKSON THOMAS W | Director | Feb 20 | Option Exercise | 4.68 | 17,500 | 81,900 | 84,948 | Feb 22 10:38 AM | | CRESCI ROBERT J | Director | Feb 20 | Option Exercise | 5.99 | 10,000 | 59,900 | 235,891 | Feb 22 10:01 AM | | ERICKSON THOMAS W | Director | Feb 20 | Sale | 17.49 | 17,500 | 306,075 | 67,448 | Feb 22 10:38 AM | | KEVER JIM D | Director | Feb 07 | Option Exercise | 5.99 | 10,000 | 59,900 | 180,844 | Feb 11 02:13 PM | | LOEWENBAUM G WALTER II | Director | Dec 06 | Option Exercise | 8.41 | 26,000 | 218,660 | 543,627 | Dec 10 10:05 AM | | REITER DAVID S | VP & General Counsel | Sep 04 | Option Exercise | 8.41 | 10,000 | 84,100 | 76,216 | Sep 06 01:28 PM | | REITER DAVID S | VP & General Counsel | Sep 04 | Sale | 20.00 | 10,000 | 200,000 | 66,216 | Sep 06 01:28 PM | | CURRIE HARRISS T | VP Finance & CFO | Aug 15 | Option Exercise | 4.68 | 68,988 | 322,864 | 179,859 | Aug 16 04:45 PM | | CURRIE HARRISS T | VP Finance & CFO | Aug 14 | Option Exercise | 4.68 | 6,012 | 28,136 | 128,466 | Aug 16 04:45 PM | | REITER DAVID S | VP, General Counsel | Jul 23 | Option Exercise | 8.41 | 10,000 | 84,100 | 67,216 | Jul 25 10:10 AM | | LOEWENBAUM G WALTER II | Director | May 24 | Sale | 22.73 | 10,000 | 227,329 | 700,935 | May 24 05:50 PM |
|
|
|
|
|
|
